SCYNEXIS INC
SCYNEXIS INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 10 | 37 | 21 | 15 | 11 | 7 | 16 | 29 | 26 | 35 | 34 | 44 | |||||
Short Term Investments | 44 | 23 | 19 | 23 | 34 | 34 | 43 | 40 | 47 | 45 | 40 | 44 | |||||
Prepaid Expense And Other Assets Current | 2 | 1 | 0 | 1 | 2 | 1 | 2 | 2 | 1 | 2 | 6 | 3 | |||||
Contract With Customer Asset Net Current | - | - | 0 | 0 | 0 | 10 | 10 | 10 | 20 | 19 | 19 | 19 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | - | - | - | 0 | 2 | |||||
Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | - | - | - | - | - | - | - | - | - | - | 0 | 13 | |||||
Deferred Costs Current | 1 | 2 | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | 56 | 63 | 40 | 49 | 56 | 52 | 72 | 80 | 95 | 102 | 102 | 129 | |||||
Investments | 17 | 13 | 16 | 0 | 2 | 13 | 16 | 16 | 11 | 14 | 24 | 17 | |||||
Deferred Costs | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Assets | 75 | 78 | 59 | 51 | 61 | 68 | 91 | 99 | 108 | 118 | 128 | 149 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 6 | 2 | 3 | 6 | 4 | 5 | 5 | 5 | 9 | 7 | 3 | |||||
Accrued Liabilities Current | 2 | 2 | 3 | 3 | 2 | 3 | 4 | 6 | 5 | 5 | 7 | 10 | |||||
Deferred Revenue Current | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | |||||
Operating Lease Liability Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Debt | - | - | - | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Liabilities Current | 6 | 16 | 6 | 8 | 11 | 9 | 24 | 26 | 25 | 27 | 16 | 17 | |||||
Deferred Revenue Noncurrent | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | |||||
Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Warrants And Rights Outstanding | 1 | 19 | 2 | 4 | 3 | 5 | 8 | 11 | 18 | 12 | 22 | 24 | |||||
Operating Lease Liability Noncurrent | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | |||||
Liabilities | 8 | 36 | 10 | 15 | 16 | 17 | 36 | 41 | 47 | 44 | 55 | 57 | |||||
Long Term Loans Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 466 | 448 | 434 | 434 | 433 | 432 | 432 | 431 | 430 | 429 | 428 | 428 | |||||
Retained Earnings Accumulated Deficit | -399 | -406 | -385 | -397 | -389 | -382 | -377 | -372 | -369 | -355 | -355 | -336 | |||||
Stockholders Equity | 67 | 41 | 49 | 36 | 44 | 51 | 55 | 59 | 60 | 74 | 73 | 92 | |||||
Liabilities And Stockholders Equity | 75 | 78 | 59 | 51 | 61 | 68 | 91 | 99 | 108 | 118 | 128 | 149 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Common Stock Shares Issued | 79 | 8 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Shares Outstanding | 79 | 8 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -28.55% | -32.80% | -26.58% | - | - | - | - | - | - | - | - | - |
| 2025 | -6.23% | -25.33% | -30.44% | 5.33% | -5.33% | -21.89% | 9.35% | -6.97% | 30.43% | 4.90% | 31.61% | -5.68% |
| 2024 | 31.25% | 8.70% | 14.67% | -23.56% | -19.90% | -23.04% | 3.79% | -24.32% | -18.94% | -7.89% | 12.50% | -4.06% |
| 2023 | - | - | - | 18.57% | -20.00% | -32.86% | -2.04% | 10.20% | 24.78% | -2.04% | 88.44% | 38.78% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 9.65 | 3.94 | 7.04 | 5.75 | 5.20 | 5.83 | 3.00 | 3.13 | 3.75 | 3.72 | 6.26 | 7.66 | |||||
| Quick Ratio | 9.39 | 3.89 | 7.00 | 5.67 | 5.06 | 5.67 | 2.90 | 3.07 | 3.69 | 3.66 | 5.92 | 6.69 | |||||
| Working Capital | 50.41M | 46.79M | 34.64M | 40.23M | 45.64M | 43.26M | 48.08M | 54.74M | 69.35M | 74.32M | 85.81M | 111.85M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.12 | 0.88 | 0.20 | 0.40 | 0.36 | 0.34 | 0.65 | 0.69 | 0.78 | 0.60 | 0.76 | 0.61 | |||||
| Interest Coverage TTM | - | - | -92.91 | -89.71 | -61.01 | -45.50 | -44.83 | -62.28 | -62.09 | 39.11 | 23.22 | 16.51 | |||||
| Debt Ratio | 0.11 | 0.47 | 0.16 | 0.29 | 0.27 | 0.26 | 0.39 | 0.41 | 0.44 | 0.37 | 0.43 | 0.38 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.28 | 0.28 | 0.28 | 0.04 | 0.04 | 0.03 | 0.03 | 0.07 | 0.07 | 1.49 | 1.30 | 1.04 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | - | - | - | - | - | 6.36 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | - | - | - | - | 57.35 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.87 | -3.85 | -1.38 | -4.06 | -3.14 | -4.38 | -3.51 | -6.00 | -5.84 | 16.69 | 11.08 | 12.06 | |||||
| Free Cash Flow Per Share TTM | -1.13 | -0.93 | -0.85 | -5.39 | -3.88 | -4.44 | -3.96 | -3.59 | -1.68 | 12.45 | 10.06 | 7.53 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | - | - | - | 91.35% | 98.66% | 97.77% | 96.73% | |||||
| Operating Profit Margin TTM | -117.70% | -119.95% | -78.03% | -1,181.04% | -1,121.64% | -1,377.15% | -990.84% | -608.64% | -537.02% | 52.60% | 51.85% | 53.92% | |||||
| Net Profit Margin TTM | -53.27% | -120.51% | -41.79% | -862.89% | -599.05% | -1,030.04% | -568.29% | -425.46% | -366.13% | 72.18% | 47.84% | 53.14% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 489.78% | 673.54% | 449.95% | -65.77% | -66.29% | -98.13% | -97.33% | -93.70% | -92.88% | 2,436.75% | 2,652.72% | 3,162.94% | |||||
| Net Income Growth (1Y) | -47.56% | -9.50% | -59.56% | -30.57% | -44.85% | -126.73% | -131.75% | -150.47% | -179.76% | -211.06% | -206.74% | -193.01% | |||||
| EPS Growth (1Y) | -72.42% | -12.20% | -60.71% | -32.35% | -46.22% | -126.09% | -131.32% | -149.72% | -178.65% | -209.94% | -195.05% | -192.26% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -4.70 | -1.91 | -3.67 | -1.52 | -1.72 | -1.74 | -2.76 | -1.99 | -2.74 | 0.70 | 1.59 | 1.51 | |||||
| P/B TTM | 0.72 | 1.13 | 0.64 | 1.05 | 0.76 | 0.93 | 1.07 | 1.24 | 1.61 | 0.96 | 1.46 | 1.19 | |||||
| P/S TTM | 2.50 | 2.30 | 1.53 | 13.10 | 10.31 | 17.89 | 15.67 | 8.46 | 10.04 | 0.51 | 0.76 | 0.80 | |||||
| Market Cap | 48.12M | 46.73M | 31.56M | 38.42M | 33.58M | 47.06M | 58.70M | 72.44M | 97.02M | 70.92M | 106.71M | 109.19M | |||||
| Enterprise Value | 37.45M | 9.87M | 10.11M | 23.44M | 22.32M | 39.58M | 42.11M | 43.17M | 70.49M | 34.90M | 72.12M | 64.58M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -13.31M | -5.92M | -5.28M | -33.59M | -24.10M | -27.47M | -24.01M | -21.84M | -10.18M | 75.08M | 60.16M | 45.09M | |||||
| Net Debt | -10.68M | -36.86M | -21.45M | -14.99M | -11.26M | -7.49M | -16.60M | -29.27M | -26.54M | -36.03M | -34.59M | -44.62M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
SCYNEXIS INC (SCYX) — SEC Financial Statements & Analysis
SCYNEXIS INC (SCYX) is a pharmaceutical preparations company. SCYNEXIS INC trades on Nasdaq as: SCYX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SCYNEXIS INC reported a 489.78% year-over-year revenue growth, a Gross Profit Margin of 91.35% (TTM), a Debt-to-Equity ratio of 0.12x, a Price-to-Sales (P/S) ratio of 2.50x (TTM), a Price-to-Book (P/B) ratio of 0.72x (TTM), at a market cap of $48.12M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 489.78%
- Gross Profit Margin TTM
- 91.35%
- Debt To Equity
- 0.12x
- P/S TTM
- 2.50x
- P/B TTM
- 0.72x
- Market Cap
- $48.12M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SCYNEXIS INC in?
SCYNEXIS INC (SCYX) operates in the Pharmaceutical Preparations industry.
What is SCYX's market cap?
SCYNEXIS INC (SCYX) has a market capitalization of $48.12M as of 2026-06-30.
What exchange does SCYX trade on?
SCYNEXIS INC (SCYX) trades on the Nasdaq.